New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Dabba Trading Scam: ED Files Prosecution Complaint In ₹404-Crore Case; Mumbai Identified As Key Operational Hub
BMC Elections 2026: Congress Demands To Accept Nomination, Affidavits In English, Shiv Sena Firm On Only Marathi
'Fed Up' In A Ward: Residents Demand 'Right to Decent Living' As BMC Polls Loom
IND vs SL 2nd T20I: Shafali Verma Blitz, Spinners Blow Sri Lanka Away, India Seal 2-0 Lead With 7-Wicket Win In Vizag
